DOI:
10.1055/s-00000133
Gastroenterologie up2date
LinksClose Window
References
Blay JY, Serrano C, Heinrich MC. et al.
Ripretinib in patients with advanced gastrointestinal stromal tumours (INVICTUS): a double-blind, randomised, placebo-controlled, phase 3 trial.
Lancet Oncol 2020;
21: 923-934
We do not assume any responsibility for the contents of the web pages of other providers.